Company Valuation: Rapport Therapeutics, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2024 2025 2026 2027 2028
Market Cap 1 648.9 1,446 1,408 - -
Change - 122.86% -2.6% - -
Enterprise Value (EV) 1 343.6 955.5 742.6 876.4 800.6
Change - 178.1% -22.29% 18.03% -8.65%
P/E -4.69x -10.6x -7.24x -5.69x -4.77x
PBR - 2.99x 2.27x 3.74x 2.88x
PEG -0.1x 0.4x -0.5x -0.2x -0.2x
Capitalization / Revenue - - 70.4x - -
EV / Revenue - - 37.1x - -
EV / EBITDA -4.18x -7.7x -4.21x -3.86x -3.04x
EV / EBIT -4.14x -7.64x -4.12x -3.46x -2.55x
EV / FCF -5.11x -10.8x -6.4x -4.65x -3.53x
FCF Yield -19.6% -9.22% -15.6% -21.5% -28.4%
Dividend per Share 2 - - - - -
Rate of return - - - - -
EPS 2 -3.78 -2.86 -3.284 -4.178 -4.981
Distribution rate - - - - -
Net sales 1 - - 20.01 - -
EBITDA 1 -82.22 -124.1 -176.5 -227.1 -263.4
EBIT 1 -83.06 -125.1 -180.3 -253.2 -314.3
Net income 1 -78.31 -111.5 -164.6 -240.4 -304.9
Net Debt 1 -305.3 -490.5 -665.9 -532.1 -607.9
Reference price 2 17.74 30.34 23.76 23.76 23.76
Nbr of stocks (in thousands) 36,576 47,661 59,280 - -
Announcement Date 3/11/25 3/10/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-7.24x37.1x-4.21x - 1.41B
17.32x6.64x12.72x1.72% 66.37B
31.83x8.5x28.08x0.07% 58.86B
38.41x6.84x20.46x0.85% 55.22B
44.35x6.2x29.52x-.--% 47.21B
33.62x3.22x13.9x-.--% 42.45B
35.98x8.9x23.21x0.36% 36.44B
-19.28x55.7x-21.11x-.--% 35.19B
41.59x8.02x26.91x-.--% 32.66B
-74.36x14.09x-75.73x-.--% 26.73B
Average 14.22x 15.52x 5.37x 0.33% 40B
Weighted average by Cap. 21.51x 11.73x 11.33x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Rapport Therapeutics, Inc.

Historical PBR trend

Valuation ratios - PBR - Rapport Therapeutics, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Rapport Therapeutics, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Rapport Therapeutics, Inc.

  1. Stock Market
  2. Stocks
  3. RAPP Stock
  4. Valuation Rapport Therapeutics, Inc.